US regulators approve Wegovy pill, first oral medication to treat obesity – The Guardian
US regulators approve Wegovy pill, first oral medication to treat obesity The Guardian With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN Weight-loss pill approval set to accelerate food industry product overhauls Reuters Novo Nordisk stock surges on hopes Wegovy pill approval will deliver ‘redemption’ for investors CNBC F.D.A. Approves Wegovy Weight-Loss […]
Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk – CNBC
Novo Nordisk’s new obesity pill, Alphabet’s data center deal, the end of EV euphoria and more in Morning Squawk CNBC With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins CNN Novo Nordisk stock surges on hopes Wegovy pill approval will deliver ‘redemption’ for investors CNBC FDA Okays Oral Semaglutide 25 mg for […]
The K-shaped economy is carrying a ticking time bomb into 2026
The GDP number arrived just before Christmas, wrapped like good news. The U.S. economy grew at a 4.3% annual rate in the third quarter, blowing past economists’ expectations and delivering the kind of headline that signals strength heading into the new year. Consumers went on an unusually strong spending tear while corporations cinched $166 billion […]
The 10 most read stories on Future Perfect in 2025
As Future Perfect has in past years, we’re spending this holiday season rounding up our most-read stories of 2025 — a quick way to see what landed with you when you had the whole internet to choose from. Looking over the list, two themes dominated. One is intensely everyday: what we eat and drink, what […]
Major Medicare Changes Announced For Certain Drugs
Access to GLP-1 weight loss drugs could improve the long-term health and well-being for millions of Americans.
CMS Unveils Model to Expand Coverage of Certain Weight Loss Drugs
The Centers for Medicare & Medicaid Services (CMS) on Monday unveiled a voluntary model designed to expand access to GLP-1 medications for weight management and metabolic health, allowing Medicare Part D plans and state Medicaid agencies to cover these drugs while negotiating lower prices to manage expenses. The Better Approaches to Lifestyle and Nutrition for […]
Where Israel Goes Next. The Real War on Christmas. Plus. . .
It’s Wednesday, December 24. This is The Front Page, your daily window into the world of The Free Press—and our take on the world at large. Today: Why Gen-Z New Yorkers are heading to church, the festive traditions under attack in Europe, the China hawks rattled by Donald Trump’s rhetoric, and much more. But first: […]
Company News for Dec 24, 2025
Shares of Novo Nordisk A/S (NVO) climbed 7.3% after the U.S. FDA approved its drug GLP-1 pill for the treatment of overweight or obesity. Huntington Ingalls Industries Inc.’s (HII) shares rose 0.3% following the U.S. government’s plan for a new “Trump class” of battleships, larger, faster and “100 times more powerful” than any previously built. […]
Incretin Drugs Tied to Lower CPAP Use in T2D and Sleep Apnea
Initiation of incretin receptor agonists vs SGLT2 inhibitors in adults with obesity, T2D, and obstructive sleep apnea is linked to lower risks for continuous positive airway pressure use and death. Medscape Medical News
How 2025 marked a turning point for health science and innovation
From GLP-1 drugs and personalised cancer vaccines to longevity experiments and regenerative therapies, 2025 marked a year when scientific breakthroughs reshaped healthcare and medicine